Brain Navi Begins IPO Counseling with First Securities Inc., Setting the Stage for Global MedTech Expansion
ZHUBEI, April 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has
{fullname}
About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts
Related posts
---
Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac
ZHUBEI CITY, June 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a medical robotics company founded in
---
BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China
Enhancing Precision and Innovation in Neurosurgical Robotics Across China ZHUBEI, March 20, 2025
---
Primo's Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.
TAIPEI, April 24, 2025 /PRNewswire/ -- Primo Biotechnology Co., Ltd. ("Primo") proudly announces
---
NX Taiwan Becomes First Japanese Company to Receive QMS Certification for Medical Devices at Its NEXT3 Warehouse in Taoyuan City
TOKYO, Feb. 17, 2025 /PRNewswire/ -- Nippon Express (Taiwan) Co., Ltd. (hereafter "NX Taiwan"), a
